Skip to content
SABS SAB Biotherapeutics, Inc. Common Stock
$3.94 0.25% +0.01
Notify me if price changes either direction
Interactive Brokers Logotype

Buy SABS stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 300.5M
Enterprise value 204.6M
Trailing PE 17.863636363636
Forward PE -4.4776287
PEG Ratio -0.47636363636364
Enterprise to EBITDA -3.712
Price to book MRQ 1.3333334

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
EBITDA -55123040
Diluted EPS TTM -0.58
Total Cash (MRQ) 107.4M
Current ratio (MRQ) 11.447
Operating Cash Flow (TTM) -51249024

SABS trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent SABS News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.